A comprehensive single-cell RNA transcriptomic analysis identifies a unique SPP1+ macrophages subgroup in aging

Wen Bi1, Mengyue Yang2, Mengjia Shi3

  • 1Department of Sports Medicine, The Sixth Affiliated Hospital of Shenzhen University, Shenzhen Nanshan People's Hospital, Shenzhen, 518052, China.

Scientific Reports
|August 5, 2024
PubMed

Insights

Aging skeletal muscle shows increased SPP1+ macrophages, linked to senescence and fat accumulation. Senolytic treatment with dasatinib + quercetin reduced these macrophages, offering a potential therapeutic target for age-related muscle weakness.

Area of Science:

  • Cellular senescence
  • Muscle biology
  • Immunology

Background:

  • Skeletal muscle (SkM) senescence contributes to age-related weakness and disability.
  • Macrophage (Mac) populations within SkM play diverse roles in aging.
  • An imbalance between damage and repair processes is implicated in declining SkM function.

Purpose of the Study:

  • To compare metabolic pathways and biological functions of cells in young and old mouse SkM.
  • To identify and characterize specific macrophage subgroups in aged SkM.
  • To investigate the therapeutic potential of targeting senescence-related macrophages.

Main Methods:

  • Comprehensive single-cell transcriptomic analysis of young and old mouse SkM.
  • Identification and characterization of macrophage subgroups.
  • Quantitative analysis of SPP1+ macrophage proportion in mouse quadriceps.
  • Assessment of senotherapeutic drug combination (dasatinib + quercetin) effects.

Main Results:

  • A unique macrophage subgroup expressing high levels of SPP1 was identified in old mouse SkM, exhibiting senescence and adipogenesis features.
  • The proportion of SPP1+ macrophages significantly increased in the quadriceps of old mice.
  • The senotherapeutic combination of dasatinib + quercetin markedly reduced the proportion of SPP1+ macrophages.

Conclusions:

  • SPP1+ macrophages represent a distinct cellular component associated with SkM aging and adipogenesis.
  • Targeting SPP1+ macrophages with senolytics like dasatinib + quercetin may offer a novel therapeutic strategy for SkM aging.
  • This study highlights SPP1+ macrophages as a potential senotherapeutic target for combating age-related muscle decline.

Related Concept Videos

Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.8K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.5K